| Title: | Association between circulating insulin-like growth factor 1 and risk of all-cause and cause-specific mortality. |
| Journal: | European Journal of Endocrinology |
| Published: | 11 Oct 2021 |
| Pubmed: | https://pubmed.ncbi.nlm.nih.gov/34478404/ |
| DOI: | https://doi.org/10.1530/eje-21-0573 |
| URL: | https://eje.bioscientifica.com/downloadpdf/journals/eje/185/5/EJE-21-0573.pdf |
Publication 4133
WARNING: the interactive features of this website use CSS3, which your browser does not support. To use the full features of this website, please update your browser.
Abstract
BACKGROUND: Insulin-like growth factor 1 (IGF1) is an important growth factor modulating development, homeostasis, and aging. However, whether and how circulating IGF1 concentrations influence early death risk in the general population remains largely unknown. METHODS: We included 380 997 participants who had serum IGF1 measurement and no history of cancer, cardiovascular disease (CVD), or diabetes at baseline from UK Biobank, a prospective cohort study initiated in 2006-2010. Restricted cubic splines and Cox proportional hazards regression models were used to assess the association between baseline IGF-1 concentrations and all-cause and cause-specific mortality. RESULTS: Over a median follow-up of 8.8 years, 10 753 of the participants died, including 6110 from cancer and 1949 from CVD. Dose-response analysis showed a U-shaped relationship between IGF1 levels and mortality. Compared to the fifth decile of IGF1, the lowest decile was associated with 39% (95% CI: 29-50%), 20% (95% CI: 8-34%), and 39% (95% CI: 14-68%) higher risk of all-cause, cancer, and CVD mortality, respectively, while the highest decile was associated with 17% (95% CI: 7-28%) and 38% (95% CI: 11-71%) higher risk of all-cause and CVD mortality, respectively. The results remained stable in detailed stratified and sensitivity analyses. CONCLUSIONS: Our findings indicate that both low and high concentrations of serum IGF1 are associated with increased risk of mortality in the general population. Our study provides a basis for future interrogation of underlying mechanisms of IGF1 in early death occurrence and possible implications for mitigating the risk.8 Authors
- Yu Xie
- Changzhi Huang
- Xingchen Zhu
- Jiayu Wang
- Xikang Fan
- Zan Fu
- Yanan Ma
- Dong Hang
Enabling scientific discoveries that improve human health